Olympus is passionate about creating customer-driven solutions for the medical sector. For over 100 years, Olympus has been pioneering innovations that elevate the standard of healthcare throughout the patient pathway. Olympus’ mission to help people everywhere fulfill their desires, curiosities, dreams, ambitions, and lives, forms a philosophy called True to Life and complements its purpose of making people's lives healthier, safer and more fulfilling.

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular, Metabolism & Retina; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension.

Follow us at www.twitter.com/JanssenGlobal
Janssen CVM is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Boston Scientific’s Endoscopy portfolio is industry-leading in its minimally invasive devices for diagnosing and treating gastrointestinal and airway conditions - committed to improving patient care through innovation, product development and support. Broad in nature, the products and solutions on offer fall within the spheres of Biliary, Dilation, Hemostasis and more.

CRK Professional Precision are the leading distributer of endoscopy related equipment and accessories across New Zealand & Australia, representing brands such as Medivators Automated Endoscope Repressors, the Scope Buddy and EndoStratus CO2 insufflator & Irrigation pump, FSN surgical Monitors, Sony Printers & media, Fujifilm Endoscopes, Simbionix Surgical Training Simulators, The Pull Thru endoscope channel cleaning device, Strong Biotech H.pylori test kits & Blackeye endoscopic marker. We will be presenting exciting new Fujifilm products; the ClutchCutter & ST distal caps for advanced EMR procedures. We look forward to welcoming you to our stand.

Celltrion Healthcare is committed to delivering innovative medications to promote patients’ access to advanced therapies. Our products include the world’s first antibody biosimilar, the world’s first subcutaneous formulation of infliximab, and the first high-concentration, low-volume, citrate-free, latex-free adalimumab biosimilar. Celltrion Healthcare endeavours to offer high-quality cost-effective solutions through an extensive global network that spans more than 110 different countries.

Bold thinking. Bolder actions. We are Medtronic.

We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world.

In everything we do, we are engineering the extraordinary.

Pharmaco is a leading sales, marketing and distribution healthcare organisation. We partner with International Pharmaceutical Companies and together we share a common goal, to provide research-based quality medicines in the areas of Gastroenterology, Inflammatory Bowel Disease and Bowel Cleansing.

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare, life sciences and dental products and services.

STERIS partners with Customers in the perioperative environment to help elevate patient care in Operating Rooms, GI / Endoscopy Suites, and Sterile Processing Departments.

Through comprehensive solutions in equipment, consumables, devices, and services, we help Customers solve their biggest challenges, leverage opportunities for future growth, and advance the care of patients every day.

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI), with expertise in immune and inflammatory diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

Douglas Pharmaceuticals is New Zealand’s largest privately owned pharmaceutical and healthcare company. It was founded in 1967 by pharmacist Sir Graeme Douglas and today employs over 700 people and exports to over 40 countries around the world.

The Douglas mission is to ‘Improve Lives’ by providing innovative, competitive, and high-quality healthcare solutions. Douglas develops, manufactures, and distributes novel and generic products, with a preference for those where there is a strong intellectual property position, technical complexity and in areas of high unmet need. One of Douglas’ key novel programmes focusses on unmet needs in IBD; developing innovative solutions to improve the lives of patients.

Fresenius Kabi is a global healthcare company that specialises in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients.

Roche New Zealand operates across two businesses, Pharmaceuticals and Diagnostics. Our aim is to enable New Zealanders access to our medicines and diagnostic tests to detect illnesses early, and to treat them with life-saving and life-changing medicines.

Because every person is unique, we are working to advance the concept of personalised healthcare – helping to prevent, diagnose and treat illnesses more effectively.

Roche is the largest investor in clinical trials in New Zealand, with approximately 50 active clinical trials running at any given time across a range of disease areas.

We have one purpose: to do now what patients need next.